GLAVI(SZ:300900)2023-04-24 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥157,745,435.57, representing a 51.36% increase compared to ¥104,220,365.77 in the same period last year[4]. - The net profit attributable to shareholders for Q1 2023 was ¥25,257,525.16, up 50.13% from ¥16,823,649.50 in the previous year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥22,116,102.41, a 40.36% increase from ¥15,756,160.39 year-on-year[4]. - Total revenue for Q1 2023 reached ¥157,745,435.57, a 51.3% increase from ¥104,220,365.77 in the same period last year[23]. - Net profit for Q1 2023 was ¥31,926,681.27, representing a 25.2% increase compared to ¥25,522,638.58 in Q1 2022[24]. - The total comprehensive income attributable to the parent company was CNY 25,257,525.16, an increase from CNY 16,823,649.50 in the previous period, representing a growth of approximately 50.5%[25]. - Basic and diluted earnings per share increased to CNY 0.12 from CNY 0.08, reflecting a 50% increase year-over-year[25]. Assets and Liabilities - The company's total assets at the end of Q1 2023 reached ¥3,937,332,981.38, a 26.24% increase from ¥3,118,825,964.97 at the end of the previous year[4]. - As of March 31, 2023, the company reported total assets of RMB 4.2048 billion and total liabilities of RMB 2.1703 billion[19]. - Total liabilities increased to ¥1,954,113,255.27 from ¥1,272,584,552.78, representing a rise of 53.5%[22]. Cash Flow - The net cash flow from operating activities was -¥40,905,475.19, a decline of 163.06% compared to -¥15,549,895.48 in the same period last year, primarily due to increased expenditures for raw material inventory and wages[9]. - Cash inflow from operating activities totaled CNY 127,908,707.98, compared to CNY 85,677,313.32 in the previous period, marking a growth of approximately 49.2%[27]. - The net cash flow from financing activities was CNY 760,295,038.68, significantly up from CNY 137,852,717.99 in the previous period, representing an increase of over 450%[28]. - The total cash and cash equivalents at the end of the period reached CNY 752,082,938.88, compared to CNY 335,645,337.40 at the end of the previous period, showing a growth of approximately 124.5%[28]. Research and Development - Research and development expenses increased by 58.01% to ¥10,197,872.55, reflecting the company's commitment to new product and technology development[8]. - The company invested ¥10,197,872.55 in R&D during Q1 2023, compared to ¥6,454,111.46 in the previous year, an increase of 57.0%[24]. Shareholder Information - The top 10 unrestricted shareholders hold a total of 36,000,000 shares, with the largest shareholder holding 7,830,833 shares[12]. - The company has a total of 78,890,950 restricted shares, with 76,250 shares released during the reporting period[15]. - The company reported a 1.99% stake held by Northeast Securities Co., Ltd., making it one of the top shareholders[12]. - The company has a total of 65,890,000 shares under lock-up due to pre-IPO restrictions, set to be released on October 29, 2023[14]. Financing Activities - The company issued convertible bonds, resulting in a net cash inflow from financing activities of ¥760,295,038.68, a significant increase from ¥137,852,717.99 in the previous year[9]. - The company issued 7 million convertible bonds with a total fundraising amount of RMB 700 million, net proceeds after fees amounted to RMB 692,047,620.51[16]. - The company plans to list the convertible bonds on April 17, 2023, under the name "Guanglian Convertible Bonds" with code 123182[18]. Strategic Initiatives - The company is focusing on market expansion and new product development as part of its strategic initiatives for 2023[15]. - The company has engaged in a financing strategy involving margin trading, with specific shareholders participating in this activity[12].